Abstract

BackgroundAnastomotic leakage (AL) in the upper gastrointestinal (GI) tract is associated with high morbidity and mortality rates. Especially intrathoracic anastomotic leakage leads to life-threatening complications. Endoscopic vacuum therapy (EVT) for anastomotic leakage after transthoracic esophageal resection represents a novel concept. However, sound clinical data are still scarce. This retrospective, single-center study aimed to evaluate the feasibility, effectiveness, and safety of EVT for intrathoracic anastomotic leakage following abdomino-thoracic esophageal resection.MethodsFrom March 2014 to September 2019 259 consecutive patients underwent elective transthoracic esophageal resection. 72 patients (27.8%) suffered from AL. The overall collective in-hospital mortality rate was 3.9% (n = 10). Data from those who underwent treatment with EVT were included.ResultsFifty-five patients were treated with EVT. Successful closure was achieved in 89.1% (n = 49) by EVT only. The EVT-associated complication rate was 5.4% (n = 3): bleeding occurred in one patient, while minor sedation-related complications were observed in two patients. The median number of EVT procedures per patient was 3. The procedures were performed at intervals of 3–5 days, with a 14-day median duration of therapy. The mortality rate of patients with AL was 7.2% (n = 4). Despite successfully terminated EVT, three patients died because of multiple organ failure, acute respiratory distress syndrome, and urosepsis (5.4%). One patient (1.8%) died during EVT due to cardiac arrest.ConclusionsEVT is a safe and effective approach for intrathoracic anastomotic leakages following abdomino-thoracic esophageal resections. It offers a high leakage-closure rate and the potential to lower leakage-related mortalities.Trial registration: This trial was registered and approved by the Institutional Ethics Committee of the University of Heidelberg on 16.04.2014 (Registration Number: S-635/2013).

Highlights

  • Anastomotic leakage is a severe and life-threatening complication that occurs after esophageal resections

  • Endoscopic vacuum therapy (EVT) was applied as the primary therapy for anastomotic leakage in 49 patients (68%)

  • A change of therapy was encountered in six patients, who were either initially treated by SEMS (n = 4) or had an unsuccessful revisional surgery (n = 2) and received EVT later

Read more

Summary

Introduction

Anastomotic leakage is a severe and life-threatening complication that occurs after esophageal resections. The reported incidence of intrathoracic anastomotic leakages after esophageal resections vary widely from 1 to 35% [8,9,10,11,12,13,14]; reported mortality rates range from 7.2 to 60% [15,16,17,18,19]. The reported mortality rates of stent therapy vary widely and range from 0 to 83% [13, 32,33,34,35]. This retrospective, single-center study aimed to evaluate the feasibil‐ ity, effectiveness, and safety of EVT for intrathoracic anastomotic leakage following abdomino-thoracic esophageal resection

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call